Latest Breaking News On - Cardiology heart failure congress - Page 1 : vimarsana.com

BioCardia Reports First Quarter 2024 Business Highlights and Financial Results

SUNNYVALE, Calif., May 14, 2024 (GLOBE NEWSWIRE) BioCardia, Inc. [Nasdaq: BCDA], a developer of cellular and cell-derived therapeutics for th.

United statesPeter altmanBiocardia incMaryland stem cell research fundEuropean society of cardiology heart failure congressMedicaid servicesExchange commissionDevice agencyCompany annual report on formExchange commission onCell therapyIschemic heart failureFailure trialHeart failure therapeuticsTherapy heart failureChronic myocardial ischemia

BioCardia : Reports First Quarter 2024 Business Highlights and Financial Results

BioCardia : Reports First Quarter 2024 Business Highlights and Financial Results
marketscreener.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from marketscreener.com Daily Mail and Mail on Sunday newspapers.

United statesPeter altmanEuropean society of cardiology heart failure congressBiocardia incExchange commission onMedicaid servicesExchange commissionMaryland stem cell research fundDevice agencyBiocardia reports first quarterFinancial resultsCell therapyIschemic heart failureFailure trialHeart failure therapeuticsTherapy heart failure

SERENADE: No Benefit, Possible Harm With Macitentan in HFpEF and PAH

In what might prove the swan song for ERAs in HF, SERENADE tried to exclude patients with fluid retention to no avail.

Northwestern universityUnited statesSan franciscoAdriaan voorsSanjiv shahJohn teerlinkUniversity of californiaMd northwestern universityMd san francisco va medical centerPhd university of groningenEuropean society of cardiology heart failure congressEuropean societyCardiology heart failure congress